Zhende Medical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003J31
CNY
88.06
1.26 (1.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Zhende Medical Co., Ltd.

Why is Zhende Medical Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of -13.03% and Operating profit at -36.96% over the last 5 years
2
The company has declared negative results in Mar'2025 after 2 consecutive positive quarters
  • NET PROFIT(HY) At CNY 152.7 MM has Grown at -35.01%
  • DEBT-EQUITY RATIO (HY) Highest at 5.96 %
  • INTEREST COVERAGE RATIO(Q) Lowest at 741.59
3
With ROE of 6.50%, it has a fair valuation with a 2.03 Price to Book Value
  • Over the past year, while the stock has generated a return of 321.13%, its profits have risen by 147% ; the PEG ratio of the company is 0.2
  • At the current price, the company has a high dividend yield of 1.5
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhende Medical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Zhende Medical Co., Ltd.
319.53%
6.76
48.89%
China Shanghai Composite
21.43%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-17.97%
EBIT Growth (5y)
-39.75%
EBIT to Interest (avg)
50.41
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.62
Tax Ratio
17.09%
Dividend Payout Ratio
30.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.27%
ROE (avg)
21.96%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
79
Industry P/E
Price to Book Value
3.67
EV to EBIT
69.68
EV to EBITDA
39.89
EV to Capital Employed
3.58
EV to Sales
4.89
PEG Ratio
NA
Dividend Yield
0.82%
ROCE (Latest)
5.13%
ROE (Latest)
4.62%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -11.68% (YoY

-23What is not working for the Company
INTEREST(Q)

At CNY 8.13 MM has Grown at 26%

INTEREST COVERAGE RATIO(Q)

Lowest at 744.7

OPERATING PROFIT(Q)

Lowest at CNY 60.56 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.05 %

PRE-TAX PROFIT(Q)

Lowest at CNY 54.31 MM

NET PROFIT(Q)

Lowest at CNY 44.33 MM

Here's what is working for Zhende Medical Co., Ltd.

Raw Material Cost
Fallen by -11.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhende Medical Co., Ltd.

Interest
At CNY 8.13 MM has Grown at 26%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 744.7
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at CNY 60.56 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 6.05 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY 54.31 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit
At CNY 54.31 MM has Fallen at -33.55%
over average net sales of the previous four periods of CNY 81.72 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
Lowest at CNY 44.33 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit
At CNY 44.33 MM has Fallen at -31.83%
over average net sales of the previous four periods of CNY 65.03 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)